Merck Vaccine President Slot Opens Up With McGlynn's Retirement
This article was originally published in The Pink Sheet Daily
Executive Summary
A consummate Merck insider, Margie McGlynn, announces her plans to retire, as the company prepares for its pending merger with Schering-Plough.
You may also be interested in...
Merck Hires Former CDC Chief Julie Gerberding To Run Its Vaccine Division
In its second move in as many weeks to tap an outsider for a key position, Merck hired Julie Gerberding, a former director of the Centers for Disease Control and Prevention, as president of its vaccines division, effective as of Jan. 25, 2010
Merck Hires Former CDC Chief Julie Gerberding To Run Its Vaccine Division
In its second move in as many weeks to tap an outsider for a key position, Merck hired Julie Gerberding, a former director of the Centers for Disease Control and Prevention, as president of its vaccines division, effective as of Jan. 25, 2010
Merck Hires Julie Gerberding, A Former CDC Chief, To Run Its Vaccine Division
The big drug maker hires a high-profile physician with a public-health pedigree to boost its stagnant vaccine division.